Abbott Laboratories Share Price CBOE
Stocks
ABT
US0028241000
Medical Equipment, Supplies & Distribution
|
Market Closed -
CBOE
16:30:00 08/09/2026 BST
|
5-day change | 1st Jan Change | ||
| 82.66 EUR | 0.00% |
|
0.00% | -28.49% |
| 09-08 | Abbott Receives FDA Approval for Device to Treat Abnormal Heart Rhythm | DJ |
| 09-08 | Abbott Receives FDA Approval for TactiFlex Duo Ablation Catheter to Treat Abnormal Heart Rhythms | CI |
| Market Cap | 187B 161B 152B 138B 258B 17,772B 260B 1,797B 695B 9,085B 704B 688B 28,785B | P/E 2026 * |
31.1x | P/E 2027 * | 23.9x |
|---|---|---|---|---|---|
| Enterprise Value | 211B 182B 171B 156B 291B 20,042B 293B 2,026B 784B 10,245B 794B 776B 32,461B | EV / Sales 2026 * |
4.2x | EV / Sales 2027 * | 3.81x |
| Free-Float |
86.16% | Yield 2026 * |
2.37% | Yield 2027 * | 2.53% |
| Markets | Quality | ||
|---|---|---|---|
NYSE
| ABT | Delayed | |
CBOE
| ABT | Real-time | |
|
Tradegate
| ABL | Real-time | |
|
London S.E.
| ABT | Delayed | |
|
Xetra
| ABL | Delayed | |
|
Boerse Muenchen
| ABL | Real-time | |
|
CBOE
| Real-time | ||
|
Deutsche Boerse AG
| ABL | Delayed | |
|
Mexican S.E.
| ABT * | End-of-day quote | |
|
Borsa Italiana
| 1ABT | End-of-day quote | |
|
Kazakhstan S.E.
| ABT_KZ | End-of-day quote | |
|
Lima
| ABTUS | End-of-day quote | |
|
Wiener Boerse
| ABT | End-of-day quote | |
|
Swiss Exchange
| ABT | Delayed | |
|
CBOE
| ABT | Real-time | |
|
Santiago S.E.
| ABTCL | End-of-day quote | |
|
Börse Stuttgart
| ABL | Delayed | |
|
Santiago S.E.
| ABT | End-of-day quote |
Last Transcript : Abbott Laboratories
| 6 months | -13.99% | ||
| Current year | -28.49% |
| 1 week | 82.66 |  | 82.66 |
| 1 month | 82.66 | | 82.66 |
| 3 years | 82.66 | | 125.16 |
| Manager | Title | Age | Since |
|---|---|---|---|
Robert Ford
CEO | Chief Executive Officer | 52 | 30/03/2020 |
Philip Boudreau
DFI | Director of Finance/CFO | 53 | 31/08/2023 |
Sabina Ewing
CIO | Chief Investment Officer | 51 | - |
| Director | Title | Age | Since |
|---|---|---|---|
Sally Blount
BRD | Director/Board Member | 64 | 08/12/2011 |
Nancy McKinstry
BRD | Director/Board Member | 67 | 08/12/2011 |
Daniel Starks
BRD | Director/Board Member | 71 | 15/02/2017 |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 50.3B 43.27B 40.7B 37.15B 69.33B 4,769B 69.68B 482B 186B 2,438B 189B 185B 7,725B | 54.65B 47B 44.22B 40.36B 75.31B 5,181B 75.7B 524B 203B 2,648B 205B 201B 8,392B |
| Net income | 6.23B 5.36B 5.04B 4.6B 8.59B 591B 8.63B 59.74B 23.1B 302B 23.4B 22.89B 957B | 7.92B 6.82B 6.41B 5.85B 10.92B 751B 10.98B 75.96B 29.37B 384B 29.76B 29.1B 1,217B |
| Net Debt | 23.94B 20.59B 19.37B 17.68B 32.99B 2,270B 33.16B 229B 88.73B 1,160B 89.89B 87.92B 3,676B | 20.96B 18.03B 16.96B 15.48B 28.88B 1,987B 29.03B 201B 77.68B 1,016B 78.69B 76.97B 3,218B |
| Date | Price | Change |
|---|---|---|
| 08/09/26 | €82.66 | 0.00% |
| 07/09/26 | €82.66 | 0.00% |
| 04/09/26 | €82.66 | 0.00% |
| 03/09/26 | €82.66 | 0.00% |
| 02/09/26 | €82.66 | 0.00% |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
Quarterly revenue - Rate of surprise
- Stock Market
- Stocks
- ABT Stock
- ABT Stock
Select your edition
All financial news and data tailored to specific country editions
